The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs

Clinical trial NCT05159245 · RECRUITING

Trial details

NCT number: NCT05159245
Sponsor: Helsinki University Central Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Cancer Solid Tumor Haematological Malignancy

Start date: 2021-12-10
Primary completion: 2026-11-25
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.